Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The CiRA Foundation is an offshoot of the Center for iPS Cell Research and Application (CiRA) and will take control of CiRA's management of iPS cells, including manufacturing and quality control, acting as a bridge for the transfer of iPS cells to industry. It was officially founded as a general incorporation foundation on September 6, 2019, but was restructured as a public interest incorporated foundation as of April 1, 2020....
The CiRA Foundation is an offshoot of the Center for iPS Cell Research and Application (CiRA) and will take control of CiRA's management of iPS cells, including manufacturing and quality control, acting as a bridge for the transfer of iPS cells to industry. It was officially founded as a general incorporation foundation on September 6, 2019, but was restructured as a public interest incorporated foundation as of April 1, 2020. It has been more than 10 years since the first human iPS cells were reported. Now, through the hard work of researchers and cooperation of patients, iPS cell technology is being used to create new medical therapies.

List your booth number for exhibitions, ask us